Learn More
Dupilumab Recombinant Human Monoclonal Antibody, Invitrogen™
Human Recombinant Monoclonal Antibody
Supplier: Thermo Scientific MA541985

Description
Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.
Dupilumab with trade name Dupixent, is an FDA-approved drug for the treatment of patients aged 6 years and older with moderate-to-severe atopic dermatitis. It is a human monoclonal antibody. Dupilumab binds to the interleukin-4 receptor alpha (IL-4R alpha) subunit shared by the interleukin (IL)-4 and IL-13 receptor complexes, thereby inhibiting IL-4 and IL-13 signaling.
Specifications
Dupilumab | |
Recombinant Monoclonal | |
Unconjugated | |
Dupixent; REGN668; SAR231893 | |
Human IL4R/CD124 | |
100 μg | |
Primary | |
-20° C, Avoid Freeze/Thaw Cycles | |
Liquid | |
Chemical |
ELISA, SDS-Page | |
2.1 mg/mL | |
PBS with no preservative; pH 7.4 | |
Human | |
Protein A | |
RUO | |
Chemical | |
Antibody | |
IgG4 κ |
Safety and Handling
Your input is important to us. Please complete this form to provide feedback related to the content on this product.